Zinc administered in combination with AR-A014418, GSK-3β inhibitor, produced synergistic effects in the FST [162], suggesting that the antidepressant-like effect of zinc depends on GSK-3, which further supports the link between zinc and mTOR with regard to depressive disorders. Here, MTOR is linked to depressive disorder.